跳至主要内容
临床试验/NCT05778682
NCT05778682尚未招募不适用

Decannulation of Tracheostomy Cannula Based on Suctioning Frequency and High-flow Oxygen Protocol in the Intensive Care Unit

Université de Sherbrooke2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年3月20日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
试验地点
2
主要终点
Time to decannulation

研究概览

简要总结

In the DECAP-ICU trial, the investigators will be focusing on the impact of a new weaning tracheostomy technique based on suctioning frequency compared to the standard practice of capping tolerance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

None, patients and physicians will know the protocol

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Weaning from mechanical ventilation for at least 24 hours
  • Randomisation must be done in 24 hours of the mechanical ventilation weaning.

排除标准

  • Sabadell > 2
  • Contraindication of decannulation : Glasgow Coma Scale <6, severe dysphagia, non permeable respiratory tracks, neuromuscular disease (expect for the ICU weakness) and long term tracheostomy.

结局指标

主要结局

Time to decannulation

时间窗: Frome date of randomisation to the date of the actual decannulation or to the date of death, whichever comes first, assessed up to 48 months.

Time between the randomisation and the decannulation

次要结局

  • Time to decannulation criteria(From date of randomisation to the date when the criteria of decannulation are met or to the date of death, whichever comes first, assessed up to 48 months.)
  • Length of stay hospital(From admission to the date when the patient is discharge of the hospital, through study completion, average of 6 to 12 months.)
  • Length of stay ICU(From admission to the date when the patient quit the ICU, through study completion, average of 6 to 12 months.)
  • ICU readmission(Through study completion, average of 6 to 12 months.)
  • Decannulation failure(Through study completion, average of 6 to 12 months.)
  • Mechanical Ventilation weaning failure(Through study completion, average of 6 to 12 months.)
  • Adverses effects(Through study completion, average of 6 to 12 months.)
  • Mortality(Through study completion, average of 6 to 12 months.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验